Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins
Jolanda van Bilsen(Netherlands Organisation for Applied Scientific Research), Erwin Roggen(Danish Geotechnical Society), Simona L. Bavaro(Institute of Sciences of Food Production), Edward F. Knol(Utrecht University), Barbara Wróblewska(InLife Institute of Animal Reproduction and Food Research, Polish Academy of Sciences), Kitty Verhoeckx(Netherlands Organisation for Applied Scientific Research), Gregory S. Ladics(DuPont (United States)), Daniel Lozano‐Ojalvo(Child Health and Development Institute), Yvonne M. Vissers(Nestlé (Switzerland)), Joost J. Smit(Utrecht University), Colette Larré(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Elena Molina(Instituto de Investigación en Ciencias de la Alimentación), Edyta Sienkiewicz‐Szłapka(University of Warmia and Mazury in Olsztyn), Raymond Pieters(Utrecht University), Linette E. M. Willemsen(Utrecht University), Harry J. Wichers(Wageningen University & Research), Sandra Denery‐Papini(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Célia M. Antunes(University of Évora)
Cited by 45
Related Papers
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
EAACI Molecular Allergology User's Guide
|Pediatric Allergy and Immunology|2016|909
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
|Human Immunology|2004|413